With Academic Collaborators, GSK To Plug For ‘Electroceuticals’
This article was originally published in Start Up
Executive Summary
GlaxoSmithKline will fund nonprofit labs across several biomedical and engineering disciplines and offer a $1 million cash prize to probe the role of neural activity in disease. The goal is to build new devices that treat a range of diseases “in their own electrical language.”